மேத்யூ ஹாரிசன் மோர்கன் ஸ்டான்லி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மேத்யூ ஹாரிசன் மோர்கன் ஸ்டான்லி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மேத்யூ ஹாரிசன் மோர்கன் ஸ்டான்லி Today - Breaking & Trending Today

Pfizer (PFE) Q2 2021 Earnings Call Transcript


Operator
Good day, everyone, and welcome to Pfizer s second-quarter 2021 earnings conference call. Today s call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, senior vice president and chief investment relations officer.
Please go ahead, sir.
Senior Vice President and Chief Investment Relations Officer
Thank you, Sylvia. Good morning. It s my pleasure to be welcoming you to Pfizer s second-quarter earnings call for the first time as the head of investor relations at Pfizer. I m joined today by Dr.
Albert Bourla, our chairman and CEO; Frank D Amelio, our CFO; Mikael Dolsten, president of worldwide research and development and medical; Angela Hwang, group president, Pfizer Biopharmaceuticals Group; John Young, our chief business officer; and Doug Lankler, general counsel. We ll begin the call with remarks by Albert, followed by a pipeline update from Mikael, and Frank will then give you his thoughts on the numbers and our ....

United States , Boston University , United Kingdom , Frank Damelio , Daniel Busby , Andrew Baum , Albert Bourla , Kerry Holford Berenberg , Chris Stevo , Carter Gould , Angela Hwang , Doug Lankler , Andrew Baum Citi , Kerry Holford , Geoff Meacham , Carter Gould Barclays , America Merrill Lynch , Matthew Harrison Morgan Stanley , Mikael Dolsten , Chris Schott , Matthew Harrison , Geoffrey Porges , John Young , Ronny Gal , Morgan Stanley , Boston Medical Center ,

Vertex Pharmaceuticals Inc (VRTX) Q1 2021 Earnings Call Transcript


Senior Vice President of Investor Relations
Good evening. Welcome to the Vertex First Quarter 2021 Financial Results Conference Call. This is Michael Partridge, Senior Vice President of Investor Relations for Vertex. Making prepared remarks on the call tonight, we have Dr. Reshma Kewalramani, Vertex s CEO and President; Stuart Arbuckle, Chief Commercial and Operations Officer and Charlie Wagner, Chief Financial Officer. We recommend that you access the webcast slides on our website as you listen to this call. This conference call is being recorded and a replay will be available on our website.
We will make forward-looking statements on this call that are subject to the risks and uncertainties discussed in detail in today s press release and in our filings with the Securities and Exchange Commission. These statements, including without limitation those regarding Vertex s marketed CF medicines, our pipeline, expectations regarding the closing of the CRISPR transaction, which ....

United States , United Kingdom , Robyn Karnauskas , Cory Kasimov , Charlesf Wagner , Charlie Wagner , Reshma Kewalramani , Gena Wang , Salveen Richter Goldman Sachs , Stuarta Arbuckle , Mohit Bansal Citigroup , Paul Matteis Stifel , Paul Matteis , Michael Partridge , Michael Yee , Phil Nadeau Cowen , Brian Abrahams , Gena Wang Barclays , Young Cantor Fitzgerald , Salveen Richter , Geoff Meacham , Liisa Bayko , Matthew Harrison Morgan Stanley , Robyn Karnauskas Truist , Brian Skorney , Liisa Bayko Evercore ,